Results 111 to 120 of about 262,714 (264)

Associations between anthropometric indicators of adiposity and body fat percentage in normal weight young adults

open access: yesAnthropological Review, 2018
The purpose of this cross-sectional study was to determine the associations between various anthropometric adiposity screening indices and body fat percentage estimated by bioelectrical impedance analysis (BIA).
Söğüt Mustafa   +2 more
doaj   +1 more source

Urinary metabolic signatures of human adiposity

open access: yesScience Translational Medicine, 2015
In a large-scale population-based metabolic phenotyping study, diverse sets of urinary metabolites, including gut microbial co-metabolites, were reproducibly associated with human adiposity. Urinary metabolites and adiposity Elliott et al.
P. Elliott   +13 more
semanticscholar   +1 more source

Chronobiology of Cancer: How Aging Fuels Oncogenesis at the Molecular Level

open access: yesAging and Cancer, EarlyView.
This graphical abstract illustrates the key biological pathways linking aging with cancer development and progression. In the upper left, cumulative exposure to ultraviolet radiation, toxins, and reactive oxygen species (ROS) causes DNA damage and genomic instability, whereas age‐related decline in repair mechanisms, such as ATM/ATR, BER, and NER ...
Anu Singh, Aroonima Misra, Sufian Zaheer
wiley   +1 more source

RNA Sequencing Resolves Cryptic Pathogenic Variants in Mitochondrial Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Mitochondrial diseases are the most common inherited metabolic disorders, characterized by pronounced clinical and genetic heterogeneity that complicates molecular diagnosis. Although DNA‐based sequencing approaches have become standard in genetic testing, up to half of patients remain without a definitive diagnosis.
Zhimei Liu   +21 more
wiley   +1 more source

Sirtuin 1 deficiency decreases bone mass and increases bone marrow adiposity in a mouse model of chronic energy deficiency

open access: yesBone Reports, 2020
Loïc Louvet   +8 more
doaj   +1 more source

Comparative Analysis of Body Composition Results Obtained by Air Displacement Plethysmography (ADP) and Bioelectrical Impedance Analysis (BIA) in Adults

open access: yesApplied Sciences
Body composition assessment provides clinical and scientific information about health, including the metabolic risks associated with low or high body fat.
Radosław Smolik   +5 more
doaj   +1 more source

Visceral Adiposity and the Risk of Metabolic Syndrome Across Body Mass Index

open access: yesJACC Cardiovascular Imaging, 2014
OBJECTIVES This study sought to evaluate differential effects of visceral fat (VF) and subcutaneous fat and their effects on metabolic syndrome (MetS) risk across body mass index (BMI) categories. BACKGROUND The regional distribution of adipose tissue is
Ravi V. Shah   +9 more
semanticscholar   +1 more source

Early Clinical, Imaging, and Pathological Characteristics of SRPK3/TTN‐Digenic Myopathy

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective SRPK3/TTN‐digenic myopathy was recently established as a skeletal muscle myopathy caused by digenic inheritance. This study characterizes the early clinical presentation of SRPK3/TTN‐digenic myopathy in one previously reported and seven newly identified pediatric patients.
Rotem Orbach   +23 more
wiley   +1 more source

The Case for BPA as an Obesogen: Contributors to the Controversy

open access: yesFrontiers in Endocrinology, 2019
Since the inception of the term endocrine disruptor, the idea that the environment is an important determinant of phenotype has motivated researchers to explore the effect of low dose exposure to BPA during organogenesis.
Beverly S. Rubin   +2 more
doaj   +1 more source

Unraveling 4‐Phenylbutyrate's Therapeutic Role in SLC6A1 Disorders: Pharmacochaperoning Over HDAC Inhibition

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Variants in SLC6A1, encoding the GABA transporter 1 (GAT‐1), cause epilepsy, autism spectrum disorder, and developmental delay via loss of GABA uptake, impaired trafficking, and ER retention. We previously found that 4‐Phenylbutyrate (PBA), an FDA‐approved drug, restores GABA uptake and reduces seizures in SLC6A1‐related disorders ...
Melissa B. DeLeeuw   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy